| Name | CHK-336 |
|---|---|
| Synonyms | 4-Thiazolecboxylic acid, 2-[4-[[4-(aminosulfonyl)-3-fluorophenyl]methyl]-5-(cyclopropylmethyl)-3-(4-fluorophenyl)-1H-pyrazol-1-yl] |
| Description | CHK-336 (Example 1) is an orally active LDHA inhibitor (IC50<1 nM) that inhibits lactate production in mouse hepatocytes. CHK-336 can be used in the study of hyperoxaluria[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C24H20F2N4O4S2 |
|---|---|
| Molecular Weight | 530.57 |